chronic low back pain. Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ??Age between 18-65 Duration of chronic low back pain for at least three months before entering the study? since one year ago Pain severity more than equal to 3 on a 0-10 numerical pain rating scale since 7 days before first assessment
Exclusion criteria
Exclusion criteria: Changes in drug and non-drug treatments since 1 month ago (before entering the study) Neuralgia or radicular pain at legs History of cardiovascular disease that cause disruption of physical function Using cardiac pacemaker, defibrillator or other metallic or electronic devices Symptoms of serious underlying conditions such as tumor, infection, vertebral compression fracture, ankylosing spondylitis or spinal stenosis Presence of nerve or tissue damage that affects pressure pain threshold measurement locations Uncontrolled diabetes Any history of neurological or psychological problems that prevent people from participating in the test or cause a person's physical or mental dysfunction Pregnant or until 1 year postnatal Any contraindication use of of transcranial alternative current stimulation such as history of neurological diseases, open wounds on the scalp and/or face. evidence of a developmental learning disability, a history of alcohol and/or substance abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pressure pain threshold. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Digital algometer.;Temporal summation of pain. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Math formula.;Conditioned pain modulation. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Math formula.;Delayed onset of muscle activity. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Surface electromyography.;Recruitment of muscle activity. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Surface electromyography.;Pain intensity. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Numeric Rating Scale.;The degree of functional disability. Timepoint: Before the first session of treatment, after the tenth session of treatment and four weeks after the end of treatment. Method of measurement: Oswestry Disability Index questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences